USPTO serial 76359549
GIGANUCLEASE
Reviewed by CopyMark Law Group
Reg. 2988451Status 710
- Filing date
- Status date
- Registration date
- Aug 30, 2005
- Examiner
- LEVINE, HOWARD B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GIGANUCLEASE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
75724 Paris Cedex 15, FR
75724 Paris Cedex 15, FR
75724 Paris Cedex 15, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Barry L. Kelmachter
BARRY L KELMACHTER BACHMAN & LAPOINTE, PC900 CHAPEL ST STE 1201NEW HAVEN, CT 06510-2802UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, biochemical, biotechnological and bacteriological products namely, polypeptides for in vivo and invitro genetic engineering, natural and engineered meganuclease and endonuclease, nucleic acid vectors encoding the natural or engineered meganuclease or endonuclease or nucleic acid vectors comprising their recognition and cleavage site; ready to use genomic recombination system comprised primarily of reagents for scientific use; cells engineered by meganuclease recombination systems for scientific research use and therapeutic use, chemical agents, biochemical, biotechnologic and bacteriological products for use in scientific research laboratories and control laboratories namely cells, reagents, and culture media; diagnostic reagents for scientific use; proteins for use in scientific research; biotechnological preparations used as molecular scissors in scientific research | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical, veterinary, and health care products, namely polypeptides for in vivo and in vitro genetic engineering for use in the treatment of cystic fibrosis, Duchesne muscular dystrophy, and Alpha 1 antitrypsin disease; natural and engineered meganucleases and endonucleases, nucleic acid vectors encoding the natural or engineered meganuclease or endonuclease or nucleic acid vectors comprising their recognition and cleavage site, all for use in the treatment of sickle cell anemia, X-SciD, and Rs-SciD; ready to use genomic recombination system comprised primarily of meganuclease recombination system for use in the treatment of muscular dystrophy; cells engineered by meganuclease recombination system for use in the treatment of genetic and viral disease, microorganism cultures and bacteriological preparations for use in the treatment of genetic and viral disease; chemotherapeutic preparations for use in the treatment of cancer; diagnostic preparations for clinical medical use | SECTION 8 - CANCELLED | — |
| 042 | Scientific and industrial research; research for others in genetic, medical, pharmaceutical, and veterinary fields; research for others in chemistry, biology, biochemistry, molecular biology, bacteriology; scientific analysis services, research and development for others of techniques of biochemical analysis, biological analysis, molecular biology techniques, research and development of new molecules intended for industry, scientific laboratory services; conducting scientific research studies relating to engineering, natural, and engineered meganuclease and endonuclease, and meganuclease recombination systems; licensing of patents and of intellectual property; computer programming for others; and development for others of software programs and multimedia products | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CELLECTIS S.A.
- Other trademarks owned by CELLECTIS S.A.
- Other trademarks owned by CELLECTIS S.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named GIGANUCLEASE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 21, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 30, 2005 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Aug 30, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 7, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 18, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 18, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 15, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jan 31, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jan 26, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 13, 2004 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Aug 10, 2004 | PAPER RECEIVED | — | |
| Aug 10, 2004 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Aug 4, 2004 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 28, 2004 | PAPER RECEIVED | — | |
| Jan 26, 2004 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 20, 2003 | CFIT | CASE FILE IN TICRS | — |
| Oct 24, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2003 | PAPER RECEIVED | — | |
| Jul 23, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Apr 7, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2003 | PAPER RECEIVED | — | |
| Mar 14, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2003 | PAPER RECEIVED | — | |
| Mar 7, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Dec 11, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2002 | PAPER RECEIVED | — | |
| Jun 19, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 3, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 26, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 26, 2002 | PAPER RECEIVED | — |